Mueller AR et al. |
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease. |
1994 |
Transplant. Proc. |
pmid:7527951
|
Kotowski M et al. |
The Importance of New Generation Sequencing (NGS) HLA Typing in Renal Transplantation-Preliminary Report. |
|
Transplant. Proc. |
pmid:29937294
|
Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Jun H et al. |
Experiences on conversion to once-daily Advagraf and sirolimus combination in stable kidney recipients. |
2014 |
Transplant. Proc. |
pmid:24655973
|
Schreier MH et al. |
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? |
1993 |
Transplant. Proc. |
pmid:7679818
|
Tze WJ et al. |
Immunohistochemical studies of pig islet xenograft in rats immunosuppressed with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513470
|
Zheng B et al. |
Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo. |
1991 |
Transplant. Proc. |
pmid:1703717
|
Perrakis A et al. |
Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome. |
2011 |
Transplant. Proc. |
pmid:22172830
|
Cherala G et al. |
Tacrolimus pharmacokinetics in Hispanic children after kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:22172831
|
Todo S et al. |
Early trials with FK 506 as primary treatment in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689886
|
Gupta S and Brennan DC |
Pneumococcal 13-Valent Conjugate Vaccine (Prevnar 13)-Associated Immune Thrombocytopenic Purpura in a Renal Transplant Recipient: A Case Report. |
|
Transplant. Proc. |
pmid:26915880
|
Stringa P et al. |
Pretreatment Combination Reduces Remote Organ Damage Secondary to Intestinal Reperfusion Injury in Mice: Follow-up Study. |
|
Transplant. Proc. |
pmid:26915870
|
Pascual J et al. |
One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation. |
2002 |
Transplant. Proc. |
pmid:11959200
|
Fougeray S et al. |
Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers. |
2011 |
Transplant. Proc. |
pmid:22099811
|
Wachtman GS et al. |
Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. |
2011 |
Transplant. Proc. |
pmid:22099837
|
Rossi G et al. |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience. |
1998 |
Transplant. Proc. |
pmid:9636562
|
Samuel D et al. |
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636563
|
Marcén R et al. |
Evolution of rejection rates and kidney graft survival: a historical analysis. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715918
|
Vilalta R et al. |
Delayed graft function is reduced with antithymocyte globulin induction in pediatric kidney transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715923
|
Todo S et al. |
Intestinal transplantation in humans under FK 506. |
1993 |
Transplant. Proc. |
pmid:7680148
|
Nakao A et al. |
Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat. |
2000 |
Transplant. Proc. |
pmid:11120044
|
Reyes J et al. |
Nutritional management of intestinal transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7680149
|
Rodrigo E et al. |
Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus. |
2005 |
Transplant. Proc. |
pmid:16386549
|
Favi E et al. |
Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up. |
2009 |
Transplant. Proc. |
pmid:19460503
|
Habucky K et al. |
The pharmacodynamics of pentobarbital following FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721282
|
Undre NA et al. |
Pharmacokinetics of tacrolimus: clinically relevant aspects. |
1999 |
Transplant. Proc. |
pmid:10576037
|
Farghali H et al. |
Effect of FK 506 chronic administration on bromosulphthalein hepatic excretion in rats. |
1991 |
Transplant. Proc. |
pmid:1721283
|
Sung RS et al. |
Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats. |
1996 |
Transplant. Proc. |
pmid:8623427
|
Pirenne J et al. |
Addition of the colon to small bowel grafts causes lethal graft-versus-host disease in FK 506-treated pigs. |
1996 |
Transplant. Proc. |
pmid:8623447
|
Mano A et al. |
Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report. |
2009 |
Transplant. Proc. |
pmid:19917396
|
Wiebe K et al. |
FK506 rescue therapy in lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636613
|
Lampreabe I et al. |
Toward personalized medicine in renal transplantation. |
2010 |
Transplant. Proc. |
pmid:20970553
|
Sato K et al. |
Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249521
|
Miyazawa H et al. |
Mechanisms of hamster kidney graft rejection in the rat. |
1994 |
Transplant. Proc. |
pmid:7518111
|
Tryphonopoulos P et al. |
The impact of Campath 1H induction in adult liver allotransplantation. |
2005 |
Transplant. Proc. |
pmid:15848669
|
Jain A et al. |
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. |
2005 |
Transplant. Proc. |
pmid:15848671
|
Abouljoud MS et al. |
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533360
|
Morozumi K et al. |
Diagnosis of chronic rejection using peritubular and glomerular capillary lesions. |
1996 |
Transplant. Proc. |
pmid:8644331
|
Azuma T et al. |
Study of graft-infiltrating cells in the rat small bowel allograft using low-dose FK 506. |
1999 |
Transplant. Proc. |
pmid:10578293
|
McCarthy SA et al. |
Effects of FK 506 and cyclosporine on T-cell tolerance: inhibition of a "protective" mechanism that regulates activation-induced apoptosis in developing thymocytes. |
1991 |
Transplant. Proc. |
pmid:1721314
|
Antoniou EA et al. |
Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation. |
1999 |
Transplant. Proc. |
pmid:10578296
|
Savikko J et al. |
Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up. |
2002 |
Transplant. Proc. |
pmid:12176405
|
Erickson L et al. |
Gene expression profiling of acute rejection and mixed lymphocyte reaction with tacrolimus immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176407
|
Pascual J et al. |
Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients. |
2006 |
Transplant. Proc. |
pmid:17097946
|
Krämer BK et al. |
Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens. |
2005 |
Transplant. Proc. |
pmid:15919467
|
Bismuth H |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533415
|
Jain AB et al. |
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. |
1991 |
Transplant. Proc. |
pmid:1721347
|
Charco R et al. |
Low incidence of hypercholesterolemia among liver transplant patients under tacrolimus monotherapy immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176482
|
Parada MT et al. |
Everolimus in lung transplantation in Chile. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172343
|
Calia R et al. |
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620041
|
Meçule A et al. |
Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen. |
2011 |
Transplant. Proc. |
pmid:21620042
|
Bardella MT et al. |
FK 506 and cyclosporine: effect on D-xylose absorption in pigs with orthotopic liver-small bowel allotransplants. |
1996 |
Transplant. Proc. |
pmid:8907937
|
Ota K |
Living donor kidney transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520622
|
Watanabe T et al. |
Effects of the endothelin-1 receptor antagonist TAK-044 on pulmonary injury in discordant xenotransplantation. |
2000 |
Transplant. Proc. |
pmid:10936270
|
Takayama K et al. |
Hepatocyte growth factor and vascular endothelial growth factor expression in pig-to-primate xenotransplanted hearts. |
2000 |
Transplant. Proc. |
pmid:10936314
|
Perico N et al. |
FK 506 does not affect the glomerular filtration rate and renal plasma flow in the rat. |
1991 |
Transplant. Proc. |
pmid:1721378
|
Veroux P et al. |
Tacrolimus-induced neurotoxicity in kidney transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12493415
|
Mieles L et al. |
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1703362
|
Wagner K et al. |
Effect of FK 506 on excretion of urinary enzymes in rats. |
1991 |
Transplant. Proc. |
pmid:1721379
|
Izbicki G et al. |
Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. |
2002 |
Transplant. Proc. |
pmid:12493439
|
Warty V et al. |
Distribution of FK 506 in plasma lipoproteins in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1703363
|
Ushigome H et al. |
Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center. |
2002 |
Transplant. Proc. |
pmid:12176533
|
Weir M |
Impact of immunosuppressive regimes on posttransplant diabetes mellitus. |
2001 |
Transplant. Proc. |
pmid:11498201
|
Kaibori M et al. |
Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083347
|
Asavakarn S et al. |
Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27320587
|
Limsrichamrern S et al. |
Correlation of Hematocrit and Tacrolimus Level in Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27320581
|
el-Ghoroury M et al. |
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123461
|
Mueller AR et al. |
Long-term follow-up in hepatitis C patients with respect to immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8962255
|
Carbajal R et al. |
Case report: boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient. |
2014 |
Transplant. Proc. |
pmid:24981811
|
Furtado A et al. |
Local immunosuppression in clinical small bowel transplantation (report of two cases). |
2000 |
Transplant. Proc. |
pmid:10995910
|
Yessayan L et al. |
Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation. |
2015 |
Transplant. Proc. |
pmid:26707323
|
Tai J et al. |
In vivo and in vitro effect of FK 506 on rat Leydig cell function. |
1991 |
Transplant. Proc. |
pmid:1721409
|
Sato Y et al. |
FK 506 suppresses class II antigen expression in regenerating livers following partial hepatectomy in the rat. |
1992 |
Transplant. Proc. |
pmid:1379761
|
Chariat MN et al. |
Basiliximab in the therapy of acute rejection after organ transplantation. |
2001 |
Transplant. Proc. |
pmid:11377567
|
Chan MC et al. |
Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. |
2002 |
Transplant. Proc. |
pmid:12176601
|
Molinaro M et al. |
Pharmacokinetics of tacrolimus during the early phase after heart transplantation. |
2001 |
Transplant. Proc. |
pmid:11377570
|
van Riemsdijk IC et al. |
Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta system. |
2002 |
Transplant. Proc. |
pmid:12176606
|
Ozkurt S et al. |
Late effects of renal transplantation on endothelial functions and cardiac morphology. |
2011 |
Transplant. Proc. |
pmid:21911132
|
Pretagostini R et al. |
Conversion from cyclosporin to tacrolimus in chronic allograft nephropathy. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267174
|
Dick TB et al. |
Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients. |
2011 |
Transplant. Proc. |
pmid:21911143
|
Abouljoud M et al. |
Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267175
|
Behr TM et al. |
Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A. |
1998 |
Transplant. Proc. |
pmid:9723333
|
Berweck S et al. |
Clinical use of the euglycemic hyperinsulinemic clamp for diagnosis of tacrolimus-induced insulin resistance after combined pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9723345
|
Collin C et al. |
Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. |
2010 |
Transplant. Proc. |
pmid:21168693
|
Slatinska J et al. |
Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience. |
2013 |
Transplant. Proc. |
pmid:23726604
|
Dikow R et al. |
Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. |
2004 |
Transplant. Proc. |
pmid:15251373
|
Katayama Y et al. |
Immunosuppressive effects of FK 506 in rat lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721441
|
Yokomise H et al. |
Immunosuppressive effects of FK 506 in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721442
|
Odocha O et al. |
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689269
|
Nalesnik MA et al. |
Toxicology of FK-506 in the Lewis rat. |
1987 |
Transplant. Proc. |
pmid:2445084
|
McCauley J et al. |
Renal transplantation under FK 506 in African-Americans: early experience. |
1993 |
Transplant. Proc. |
pmid:7689270
|
Ochiai T et al. |
Histopathologic studies in renal transplant recipient dogs receiving treatment with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445085
|
Heffron TG et al. |
Single-dose induction with daclizumab immediately after liver transplantation in pediatric patients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267368
|
Bárcena R et al. |
Immunosuppression in liver transplantation: a European survey. |
1999 |
Transplant. Proc. |
pmid:10500654
|
Nicholson ML et al. |
Is TGF-beta a profibrotic cytokine in human renal transplants? |
1998 |
Transplant. Proc. |
pmid:9636384
|
Fu Q et al. |
Risk Factors for Acute Rejection After Deceased Donor Kidney Transplantation in China. |
2018 |
Transplant. Proc. |
pmid:30316380
|
Lautenschlager I et al. |
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts. |
1991 |
Transplant. Proc. |
pmid:1714650
|
Ikeda M et al. |
Successful Second Allogeneic Stem Cell Transplantation From a Sibling Donor for Relapse of Myelodysplastic Syndrome in a Recipient of a Renal Transplant From His Mother: Case Report. |
2016 |
Transplant. Proc. |
pmid:27932152
|
Filler G |
Optimization of immunosuppressive drug monitoring in children. |
2007 |
Transplant. Proc. |
pmid:17524944
|
Carl S et al. |
Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept. |
1998 |
Transplant. Proc. |
pmid:9636502
|